Vodis Pharmaceuticals, Inc.
Company Description:
Vodis Pharmaceuticals Inc. (CSE:VP) (OTC:VDQSF) (FRA:1JV) is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under license from Health Canada in accordance with the existing Narcotic Control Regulations (“NCR”) and the new Marihuana for Medical Purposes Regulations (“MMPR”) that came into effect on April 1st, 2014.